Dr. Baruch Friedman, MD

Dr. Friedman practices at Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium.

Dr. Friedman's NPI, 1174591713, was assigned on March 9, 2006. Dr. Friedman holds Maryland license D37565.

Dr. Friedman's primary practice is Alaska Native Medical Center, at 4315 Diplomacy Dr, Anchorage, AK 99508 in Anchorage Borough. The practice phone is (907) 563-2662.

Dr. Friedman's primary practice is Alaska Native Medical Center in Anchorage, Alaska, part of Alaska Native Tribal Health Consortium. The medical group on file is Alaska Native Medical Center. Dmand AI also links Dr. Friedman to 1 more medical group, named with a free account. Dr. Friedman's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Friedman practices. Vendor and product names are available with a free account.

Allergy is Dr. Friedman's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Friedman is board certified in internal medicine by the American Board of Internal Medicine. Dr. Friedman is licensed in Maryland.

CMS data shows 15 Medicare services from Dr. Friedman across 1 procedure code in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $1,433 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Friedman in 2024. The largest group is 65 to 74, with 21 patients. 58% of them have high blood pressure, and 48% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Friedman's median patient age at 70, with 60% women.

In 2024, Dr. Friedman wrote 95 Medicare Part D claims for 30 patients. 77% of them were for generic drugs. CMS names the drug for 47 of them, across 3 drugs with 11 or more claims each, at $1,556 in total drug cost. In 2023, CMS named 47 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Friedman for performance year 2024, reported as part of a group. Dr. Friedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Friedman as offering telehealth.

CMS Open Payments shows 5 general payments to Dr. Friedman from 2 drug and device companies in 2017. Education make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $107.